Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome

BACKGROUND: Down syndrome (DS) may be considered a genetic form of Alzheimer’s disease (AD) due to universal development of AD neuropathology, but diagnosis and treatment trials are hampered by a lack of reliable blood biomarkers. A potential biomarker is neurofilament light (NF-L), due to its assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Strydom, Andre, Heslegrave, Amanda, Startin, Carla M., Mok, Kin Y., Hardy, John, Groet, Jurgen, Nizetic, Dean, Zetterberg, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891918/
https://www.ncbi.nlm.nih.gov/pubmed/29631614
http://dx.doi.org/10.1186/s13195-018-0367-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891918/
https://www.ncbi.nlm.nih.gov/pubmed/29631614
http://dx.doi.org/10.1186/s13195-018-0367-x

Ejemplares similares